Free Trial
NASDAQ:BLAC

Bellevue Life Sciences Acquisition (BLAC) Stock Price, News & Analysis

$10.75
0.00 (0.00%)
(As of 06/14/2024 ET)
Today's Range
$10.75
$10.75
50-Day Range
$10.69
$10.91
52-Week Range
$10.21
$11.60
Volume
12 shs
Average Volume
101 shs
Market Capitalization
$60.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Bellevue Life Sciences Acquisition

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

BLAC Stock Price History

BLAC Stock News Headlines

See More Headlines
Receive BLAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
6/15/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:BLAC
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
4,200,000
Market Cap
$60.42 million
Optionable
Not Optionable
Beta
-0.03
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

BLAC Stock Analysis - Frequently Asked Questions

How have BLAC shares performed in 2024?

Bellevue Life Sciences Acquisition's stock was trading at $10.50 at the beginning of the year. Since then, BLAC stock has increased by 2.4% and is now trading at $10.75.
View the best growth stocks for 2024 here
.

Who are Bellevue Life Sciences Acquisition's major shareholders?

Bellevue Life Sciences Acquisition's stock is owned by many different institutional and retail investors. Top institutional shareholders include Berkley W R Corp (5.74%), Wealthspring Capital LLC (0.61%) and K2 Principal Fund L.P. (0.60%).

How do I buy shares of Bellevue Life Sciences Acquisition?

Shares of BLAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BLAC) was last updated on 6/15/2024 by MarketBeat.com Staff

From Our Partners